Description

7-(5-Chloro-2-Methylphenyl)-2-Ethyl-7H-Pyrazolo[4,3-E][1,2,4]Triazolo[1,5-C]Pyrimidine is a high-purity, heterocyclic organic compound of significant interest in advanced pharmaceutical research and development. This complex fused-ring structure serves as a critical intermediate or active scaffold for the synthesis of novel therapeutic agents. It is primarily utilized by research institutions and pharmaceutical companies engaged in drug discovery programs. The compound's specific molecular architecture makes it valuable for targeting various biological pathways.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Biochemical Research: Used as a reference standard or probe compound in enzymatic assays and receptor binding studies to investigate biological mechanisms.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties of lead molecules.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and pre-clinical development of new chemical entities (NCEs).
• Academic Research: Utilized in university and institutional labs for fundamental research in heterocyclic chemistry and drug design methodologies.

Basic Information

Product Name	7-(5-Chloro-2-Methylphenyl)-2-Ethyl-7H-Pyrazolo[4,3-E][1,2,4]Triazolo[1,5-C]Pyrimidine
CAS No.	848743-25-9
Molecular Formula	C₁₇H₁₅ClN₆
Molecular Weight	338.80 g/mol
Synonyms	7-(5-Chloro-2-methylphenyl)-2-ethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine; 2-Ethyl-7-(5-chloro-2-methylphenyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine; 848743-25-9; Pyrazolotriazolopyrimidine derivative; A2A Adenosine Receptor Antagonist Intermediate; SCH 58261 Intermediate; ZM 241385 Analog Intermediate
EINECS	Contact for details

Quality Control

Our 7-(5-Chloro-2-Methylphenyl)-2-Ethyl-7H-Pyrazolo[4,3-E][1,2,4]Triazolo[1,5-C]Pyrimidine is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide detailed Certificates of Analysis (COA) with each shipment, documenting all critical quality attributes. Our production adheres to cGMP guidelines where applicable, ensuring reliability for research and development purposes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area and protected from moisture. For long-term storage, consider inert atmosphere conditions to ensure maximum stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.